Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Pharmaceutical Consulting Services: Key Insights for Success in Eastvale, CA

Mar 17, 2025

Understanding the Pharmaceutical Consulting Landscape in Eastvale, CA

Pharmaceutical consulting services have become a cornerstone for businesses looking to thrive in the competitive healthcare industry. In Eastvale, CA, a region known for its burgeoning pharmaceutical sector, these services provide essential guidance to companies aiming to navigate complex regulatory landscapes and drive innovation. As the demand for expert advice continues to grow, understanding the key insights for success in pharmaceutical consulting is crucial for stakeholders in this dynamic market.

pharmaceutical consulting

The Importance of Regulatory Compliance

One of the primary challenges that pharmaceutical companies face is adhering to stringent regulatory requirements. In Eastvale, CA, staying compliant with both state and federal regulations is vital for maintaining operational integrity and avoiding costly penalties. Pharmaceutical consultants play a pivotal role in this process by offering specialized knowledge and strategies to ensure compliance. Their expertise helps companies streamline their operations, reduce risks, and maintain a competitive edge.

Consultants often assist in developing comprehensive compliance programs tailored to the specific needs of each client. These programs include proactive measures such as regular audits, employee training, and updates on regulatory changes. By fostering a culture of compliance, pharmaceutical companies can build trust with stakeholders and enhance their reputation in the market.

regulatory compliance

Driving Innovation and Competitive Advantage

Innovation is at the heart of the pharmaceutical industry, and consulting services are instrumental in fostering this innovation. In Eastvale, consultants help businesses by identifying opportunities for growth, advising on the latest technological advancements, and facilitating partnerships that drive research and development. By leveraging these insights, companies can develop cutting-edge products that meet evolving market demands.

Moreover, consultants provide valuable market analysis to help companies understand consumer trends and position themselves strategically. This competitive advantage enables businesses to remain agile and responsive to changes within the industry. Ultimately, investing in pharmaceutical consulting services can lead to significant breakthroughs and long-term success.

innovation healthcare

Enhancing Operational Efficiency

Operational efficiency is another critical area where pharmaceutical consulting services make a profound impact. Consultants work closely with companies to identify inefficiencies within their processes and implement solutions that optimize performance. This includes streamlining supply chains, improving production methods, and adopting new technologies that enhance productivity.

By focusing on efficiency, pharmaceutical companies in Eastvale can reduce costs, increase profitability, and improve their overall competitive position. Additionally, efficient operations contribute to faster product development cycles, allowing companies to bring innovative solutions to market more rapidly.

Building Strong Collaborative Networks

The success of a pharmaceutical company often depends on its ability to collaborate effectively with various stakeholders. Pharmaceutical consultants facilitate these collaborations by connecting businesses with key industry players such as research institutions, healthcare providers, and government agencies. These partnerships are essential for driving innovation, expanding market reach, and achieving business goals.

In Eastvale, CA, consultants leverage their extensive networks to foster collaborations that benefit all parties involved. By building strong relationships within the industry, pharmaceutical companies can access new markets, share resources, and develop innovative solutions that address pressing healthcare challenges.

Conclusion: The Path to Success

Pharmaceutical consulting services offer invaluable support to companies operating in Eastvale, CA's dynamic healthcare landscape. By providing expertise in regulatory compliance, driving innovation, enhancing operational efficiency, and building collaborative networks, consultants empower businesses to achieve their strategic objectives. As the demand for these services continues to grow, companies that invest in expert guidance are well-positioned to succeed in this competitive industry.